Genespire

Series-B+
genespire.com Biotech & Healthcare Milan, Italy 1-10
Total Funding $69.3M
Latest Round $52M Series-B+
Last Announced Sep 25, 2024
Investors 4 Backers
Decision Makers 5 Verified

About Genespire

Developing transformative gene therapies for people affected by genetic diseases

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Milan, Italy
Team Size 1-10
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website genespire.com
Domain Registered Date Oct 11, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $52,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $17,347,200 · Series-A

  3. Milestone

    Website domain registered

    genespire.com

Investors & Backers

4
CDP Venture Capital
Indaco Venture Partners
Sofinnova Partners
XGEN Venture

Funding History

2 Rounds
Series-B+ · Sep 25, 2024
Series-A · Apr 29, 2020
$17,347,200 Source

Founders & Leadership

8

Alessio Cantore

co-founder

Work email & phone locked Unlock →

Julia Berretta

Chief Executive Officer

Work email & phone locked Unlock →

Julianne Smith

Chief Development Officer

Work email & phone locked Unlock →

Karen Pignet-Aiach

CEO

Work email & phone locked Unlock →

Lucia Faccio

Chief Executive Officer

Work email & phone locked Unlock →

Luigi Naldini

co-founder

Work email & phone locked Unlock →

Philippe Mauberna

Chief Financial Officer

Work email & phone locked Unlock →

Sabah Sallah

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts